Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00668954 · ClinicalTrials.gov registry record · NA
Antioxidant Effects of Pomegranate Juice Versus Placebo in Adults With Type 2 Diabetes Mellitus
A NA study of Type 2 Diabetes Mellitus, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT00668954: Completed NA study of Type 2 Diabetes Mellitus, sponsored by University of Colorado, Denver.
NCT00668954 is a NA study of Type 2 Diabetes Mellitus that has completed, run by University of Colorado, Denver. The registered enrollment target is 26 participants, below the 2,960-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00668954, a NA study of Type 2 Diabetes Mellitus, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study designed to look at how pomegranate juice (or a placebo juice) affects the body through the measurement of specific biomarkers, which are indicators of health.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Pomegranate Juice
- DIETARY_SUPPLEMENT Placebo Juice
Study Locations (1)
Colorado
- University of Colorado Denver Center for Human Nutrition - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-11 |
| Phase | NA |
What the finished NCT00668954 record still lists
NCT00668954 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 2,960-participant average among 130 other Type 2 Diabetes Mellitus trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Pomegranate Juice is the first listed.
NCT00668954 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT00668954 about?
NCT00668954 is a clinical study titled "Antioxidant Effects of Pomegranate Juice Versus Placebo in Adults With Type 2 Diabetes Mellitus". This is a research study designed to look at how pomegranate juice (or a placebo juice) affects the body through the measurement of specific biomarkers, which are indicators of health.
What is the current status of trial NCT00668954?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2008-04. Estimated completion is 2010-11.
What conditions does trial NCT00668954 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.
What interventions are being tested in trial NCT00668954?
The interventions under investigation include: Pomegranate Juice (DIETARY_SUPPLEMENT), Placebo Juice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00668954?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00668954 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00668954's enrollment target sits among peer trials
26 97th of 130 higher than 34 of 130 other Type 2 Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
The GRoceries Aimed at Increasing Nutrition Study
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
RECRUITING · NA
-
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
ACTIVE NOT RECRUITING · NA
-
Is the Degree of Perceived Effort During Resistance Exercise Important for Improvements in Blood Glucose
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia